KR20050084550A

KR20050084550A - Ｎｅｌｌ-1 향상 골 무기질화

Ｎｅｌｌ-1 향상 골 무기질화 Download PDF

Info

Publication number: KR20050084550A
Authority: KR; South Korea
Prior art keywords: nell; expression; activity; protein; bone
Prior art date: 2002-09-13
Legal status : Ceased

Application number

KR1020057004382A

Other languages

English (en)

Korean (ko)

Inventor

강 팅

Original Assignee

더 리젠츠 오브 더 유니버시티 오브 캘리포니아

Priority date

2002-09-13

Filing date

2003-09-15

Publication date

2005-08-26

2003-09-15 Application filed by 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 filed Critical 더 리젠츠 오브 더 유니버시티 오브 캘리포니아

2005-08-26 Publication of KR20050084550A publication Critical patent/KR20050084550A/ko

Status Ceased legal-status Critical Current

Links

230000018678 bone mineralization Effects 0.000 title claims abstract description 27
108090000623 proteins and genes Proteins 0.000 claims abstract description 199
238000012216 screening Methods 0.000 claims abstract description 31
210000004027 cell Anatomy 0.000 claims description 200
238000000034 method Methods 0.000 claims description 157
230000014509 gene expression Effects 0.000 claims description 153
150000007523 nucleic acids Chemical class 0.000 claims description 139
102000004169 proteins and genes Human genes 0.000 claims description 133
102000039446 nucleic acids Human genes 0.000 claims description 119
108020004707 nucleic acids Proteins 0.000 claims description 119
210000000988 bone and bone Anatomy 0.000 claims description 116
230000000694 effects Effects 0.000 claims description 92
238000012360 testing method Methods 0.000 claims description 81
239000003795 chemical substances by application Substances 0.000 claims description 79
239000000523 sample Substances 0.000 claims description 78
238000009396 hybridization Methods 0.000 claims description 76
108020004999 messenger RNA Proteins 0.000 claims description 46
230000004072 osteoblast differentiation Effects 0.000 claims description 38
101150086605 Runx2 gene Proteins 0.000 claims description 35
101150118570 Msx2 gene Proteins 0.000 claims description 34
230000001965 increasing effect Effects 0.000 claims description 34
230000033558 biomineral tissue development Effects 0.000 claims description 33
210000001519 tissue Anatomy 0.000 claims description 32
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 31
108020004414 DNA Proteins 0.000 claims description 29
238000000338 in vitro Methods 0.000 claims description 20
241000124008 Mammalia Species 0.000 claims description 19
238000001514 detection method Methods 0.000 claims description 18
230000003321 amplification Effects 0.000 claims description 17
238000003199 nucleic acid amplification method Methods 0.000 claims description 17
238000006243 chemical reaction Methods 0.000 claims description 13
210000004714 cranial suture Anatomy 0.000 claims description 12
230000004069 differentiation Effects 0.000 claims description 12
238000002105 Southern blotting Methods 0.000 claims description 11
238000001262 western blot Methods 0.000 claims description 11
239000012472 biological sample Substances 0.000 claims description 10
230000002829 reductive effect Effects 0.000 claims description 10
238000002965 ELISA Methods 0.000 claims description 9
238000011161 development Methods 0.000 claims description 9
230000002159 abnormal effect Effects 0.000 claims description 8
230000008859 change Effects 0.000 claims description 8
230000018109 developmental process Effects 0.000 claims description 8
238000001415 gene therapy Methods 0.000 claims description 8
238000000636 Northern blotting Methods 0.000 claims description 7
230000009471 action Effects 0.000 claims description 7
230000000692 anti-sense effect Effects 0.000 claims description 7
238000003364 immunohistochemistry Methods 0.000 claims description 7
230000001105 regulatory effect Effects 0.000 claims description 7
102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 6
108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 6
238000001042 affinity chromatography Methods 0.000 claims description 5
238000005251 capillar electrophoresis Methods 0.000 claims description 5
238000007901 in situ hybridization Methods 0.000 claims description 5
238000011065 in-situ storage Methods 0.000 claims description 5
238000005259 measurement Methods 0.000 claims description 5
239000013642 negative control Substances 0.000 claims description 5
239000000546 pharmaceutical excipient Substances 0.000 claims description 5
102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims description 4
101800002279 Transforming growth factor beta-1 Proteins 0.000 claims description 4
230000004913 activation Effects 0.000 claims description 4
238000003317 immunochromatography Methods 0.000 claims description 4
238000004949 mass spectrometry Methods 0.000 claims description 4
239000008194 pharmaceutical composition Substances 0.000 claims description 4
230000001737 promoting effect Effects 0.000 claims description 4
230000003213 activating effect Effects 0.000 claims description 3
239000013543 active substance Substances 0.000 claims description 3
230000014759 maintenance of location Effects 0.000 claims description 3
239000013641 positive control Substances 0.000 claims description 3
102000053642 Catalytic RNA Human genes 0.000 claims description 2
108090000994 Catalytic RNA Proteins 0.000 claims description 2
108091027757 Deoxyribozyme Proteins 0.000 claims description 2
108091030071 RNAI Proteins 0.000 claims description 2
230000001276 controlling effect Effects 0.000 claims description 2
230000009368 gene silencing by RNA Effects 0.000 claims description 2
210000004962 mammalian cell Anatomy 0.000 claims description 2
108091092562 ribozyme Proteins 0.000 claims description 2
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 2
108700013585 MSX2 Proteins 0.000 claims 1
241000282414 Homo sapiens Species 0.000 abstract description 25
230000008439 repair process Effects 0.000 abstract description 10
208000010392 Bone Fractures Diseases 0.000 abstract description 2
230000037182 bone density Effects 0.000 abstract 1
235000018102 proteins Nutrition 0.000 description 117
108090000765 processed proteins & peptides Proteins 0.000 description 64
102000004196 processed proteins & peptides Human genes 0.000 description 57
238000003556 assay Methods 0.000 description 55
229920001184 polypeptide Polymers 0.000 description 53
241000699670 Mus sp. Species 0.000 description 43
239000000463 material Substances 0.000 description 43
239000000126 substance Substances 0.000 description 35
230000027455 binding Effects 0.000 description 34
230000002018 overexpression Effects 0.000 description 34
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 30
210000000963 osteoblast Anatomy 0.000 description 30
150000001875 compounds Chemical class 0.000 description 28
206010017076 Fracture Diseases 0.000 description 26
238000003752 polymerase chain reaction Methods 0.000 description 24
239000000203 mixture Substances 0.000 description 23
238000004458 analytical method Methods 0.000 description 22
210000000130 stem cell Anatomy 0.000 description 22
239000013598 vector Substances 0.000 description 21
108010005774 beta-Galactosidase Proteins 0.000 description 20
238000003018 immunoassay Methods 0.000 description 20
208000015181 infectious disease Diseases 0.000 description 18
241000700159 Rattus Species 0.000 description 17
239000002299 complementary DNA Substances 0.000 description 17
241001465754 Metazoa Species 0.000 description 16
238000011830 transgenic mouse model Methods 0.000 description 16
235000010323 ascorbic acid Nutrition 0.000 description 15
229960005070 ascorbic acid Drugs 0.000 description 15
239000011668 ascorbic acid Substances 0.000 description 15
238000001727 in vivo Methods 0.000 description 15
230000011164 ossification Effects 0.000 description 15
108010035532 Collagen Proteins 0.000 description 14
102000008186 Collagen Human genes 0.000 description 14
241000699660 Mus musculus Species 0.000 description 14
102000004264 Osteopontin Human genes 0.000 description 14
108010081689 Osteopontin Proteins 0.000 description 14
239000000427 antigen Substances 0.000 description 14
WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 14
229920001436 collagen Polymers 0.000 description 14
238000010186 staining Methods 0.000 description 14
230000009261 transgenic effect Effects 0.000 description 14
108091007433 antigens Proteins 0.000 description 13
102000036639 antigens Human genes 0.000 description 13
230000002188 osteogenic effect Effects 0.000 description 13
238000011282 treatment Methods 0.000 description 13
102000002260 Alkaline Phosphatase Human genes 0.000 description 12
108020004774 Alkaline Phosphatase Proteins 0.000 description 12
102000004190 Enzymes Human genes 0.000 description 12
108090000790 Enzymes Proteins 0.000 description 12
208000012868 Overgrowth Diseases 0.000 description 12
230000015572 biosynthetic process Effects 0.000 description 12
102000005962 receptors Human genes 0.000 description 12
108020003175 receptors Proteins 0.000 description 12
238000013518 transcription Methods 0.000 description 12
230000035897 transcription Effects 0.000 description 12
108010021625 Immunoglobulin Fragments Proteins 0.000 description 11
102000004067 Osteocalcin Human genes 0.000 description 11
108090000573 Osteocalcin Proteins 0.000 description 11
238000002372 labelling Methods 0.000 description 11
239000003446 ligand Substances 0.000 description 11
102000008394 Immunoglobulin Fragments Human genes 0.000 description 10
241000699666 Mus <mouse, genus> Species 0.000 description 10
230000003828 downregulation Effects 0.000 description 10
230000001605 fetal effect Effects 0.000 description 10
210000003128 head Anatomy 0.000 description 10
210000003625 skull Anatomy 0.000 description 10
108700019146 Transgenes Proteins 0.000 description 9
239000012491 analyte Substances 0.000 description 9
-1 carbocyclic sugars Chemical class 0.000 description 9
239000003153 chemical reaction reagent Substances 0.000 description 9
239000012634 fragment Substances 0.000 description 9
230000006870 function Effects 0.000 description 9
238000002493 microarray Methods 0.000 description 9
241000701161 unidentified adenovirus Species 0.000 description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
238000000137 annealing Methods 0.000 description 8
239000007850 fluorescent dye Substances 0.000 description 8
239000007943 implant Substances 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
230000002028 premature Effects 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
238000000159 protein binding assay Methods 0.000 description 8
235000002639 sodium chloride Nutrition 0.000 description 8
239000007787 solid Substances 0.000 description 8
230000003827 upregulation Effects 0.000 description 8
108020004711 Nucleic Acid Probes Proteins 0.000 description 7
208000001132 Osteoporosis Diseases 0.000 description 7
241000700605 Viruses Species 0.000 description 7
238000003491 array Methods 0.000 description 7
238000004113 cell culture Methods 0.000 description 7
230000000295 complement effect Effects 0.000 description 7
230000007423 decrease Effects 0.000 description 7
230000007547 defect Effects 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
230000004048 modification Effects 0.000 description 7
238000012986 modification Methods 0.000 description 7
230000035772 mutation Effects 0.000 description 7
239000002853 nucleic acid probe Substances 0.000 description 7
239000002773 nucleotide Substances 0.000 description 7
125000003729 nucleotide group Chemical group 0.000 description 7
210000005009 osteogenic cell Anatomy 0.000 description 7
238000011084 recovery Methods 0.000 description 7
239000000758 substrate Substances 0.000 description 7
108700039887 Essential Genes Proteins 0.000 description 6
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
101100113588 Homo sapiens CS gene Proteins 0.000 description 6
150000001413 amino acids Chemical group 0.000 description 6
210000004556 brain Anatomy 0.000 description 6
239000000872 buffer Substances 0.000 description 6
238000001962 electrophoresis Methods 0.000 description 6
230000004927 fusion Effects 0.000 description 6
230000003993 interaction Effects 0.000 description 6
239000011159 matrix material Substances 0.000 description 6
230000007246 mechanism Effects 0.000 description 6
239000012528 membrane Substances 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
230000002062 proliferating effect Effects 0.000 description 6
238000011002 quantification Methods 0.000 description 6
239000000243 solution Substances 0.000 description 6
208000011580 syndromic disease Diseases 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
238000001890 transfection Methods 0.000 description 6
230000005945 translocation Effects 0.000 description 6
239000003981 vehicle Substances 0.000 description 6
102100026189 Beta-galactosidase Human genes 0.000 description 5
101100206332 Homo sapiens GTF2A1 gene Proteins 0.000 description 5
102100034349 Integrase Human genes 0.000 description 5
108091005461 Nucleic proteins Proteins 0.000 description 5
102100030879 Transcription initiation factor IIA subunit 1 Human genes 0.000 description 5
235000001014 amino acid Nutrition 0.000 description 5
238000010171 animal model Methods 0.000 description 5
150000001720 carbohydrates Chemical group 0.000 description 5
239000000919 ceramic Substances 0.000 description 5
210000001612 chondrocyte Anatomy 0.000 description 5
230000001815 facial effect Effects 0.000 description 5
210000002950 fibroblast Anatomy 0.000 description 5
239000000499 gel Substances 0.000 description 5
239000003102 growth factor Substances 0.000 description 5
238000002595 magnetic resonance imaging Methods 0.000 description 5
230000036244 malformation Effects 0.000 description 5
239000003550 marker Substances 0.000 description 5
238000005457 optimization Methods 0.000 description 5
230000035935 pregnancy Effects 0.000 description 5
230000008569 process Effects 0.000 description 5
238000001179 sorption measurement Methods 0.000 description 5
241000894007 species Species 0.000 description 5
238000005406 washing Methods 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 4
101000661807 Homo sapiens Suppressor of tumorigenicity 14 protein Proteins 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
238000000692 Student's t-test Methods 0.000 description 4
108010046722 Thrombospondin 1 Proteins 0.000 description 4
102100036034 Thrombospondin-1 Human genes 0.000 description 4
208000027418 Wounds and injury Diseases 0.000 description 4
230000005856 abnormality Effects 0.000 description 4
238000013459 approach Methods 0.000 description 4
238000002820 assay format Methods 0.000 description 4
229940049706 benzodiazepine Drugs 0.000 description 4
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
229960002685 biotin Drugs 0.000 description 4
239000011616 biotin Substances 0.000 description 4
210000002805 bone matrix Anatomy 0.000 description 4
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
230000006378 damage Effects 0.000 description 4
239000003937 drug carrier Substances 0.000 description 4
239000000975 dye Substances 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
101150016624 fgfr1 gene Proteins 0.000 description 4
238000000684 flow cytometry Methods 0.000 description 4
239000011521 glass Substances 0.000 description 4
230000002209 hydrophobic effect Effects 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
238000011005 laboratory method Methods 0.000 description 4
238000007834 ligase chain reaction Methods 0.000 description 4
239000002609 medium Substances 0.000 description 4
238000010208 microarray analysis Methods 0.000 description 4
230000000921 morphogenic effect Effects 0.000 description 4
238000007899 nucleic acid hybridization Methods 0.000 description 4
239000013612 plasmid Substances 0.000 description 4
239000002243 precursor Substances 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
230000004952 protein activity Effects 0.000 description 4
230000010076 replication Effects 0.000 description 4
238000003757 reverse transcription PCR Methods 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
210000001103 thalamus Anatomy 0.000 description 4
102000015775 Core Binding Factor Alpha 1 Subunit Human genes 0.000 description 3
108010024682 Core Binding Factor Alpha 1 Subunit Proteins 0.000 description 3
241001442234 Cosa Species 0.000 description 3
101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 3
241000282412 Homo Species 0.000 description 3
101100536203 Homo sapiens GTF2A2 gene Proteins 0.000 description 3
241000725303 Human immunodeficiency virus Species 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
102100037942 Suppressor of tumorigenicity 14 protein Human genes 0.000 description 3
102100028604 Transcription initiation factor IIA subunit 2 Human genes 0.000 description 3
239000002253 acid Substances 0.000 description 3
239000003080 antimitotic agent Substances 0.000 description 3
239000011324 bead Substances 0.000 description 3
230000008468 bone growth Effects 0.000 description 3
239000001506 calcium phosphate Substances 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
230000004663 cell proliferation Effects 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
238000005859 coupling reaction Methods 0.000 description 3
230000008226 craniofacial development Effects 0.000 description 3
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
235000018417 cysteine Nutrition 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
230000029087 digestion Effects 0.000 description 3
239000003814 drug Substances 0.000 description 3
230000007613 environmental effect Effects 0.000 description 3
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
230000012010 growth Effects 0.000 description 3
238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 3
229910052588 hydroxylapatite Inorganic materials 0.000 description 3
238000001802 infusion Methods 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
208000014674 injury Diseases 0.000 description 3
230000010354 integration Effects 0.000 description 3
239000004816 latex Substances 0.000 description 3
229920000126 latex Polymers 0.000 description 3
150000002611 lead compounds Chemical class 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
210000002997 osteoclast Anatomy 0.000 description 3
239000002245 particle Substances 0.000 description 3
230000037361 pathway Effects 0.000 description 3
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
229920000747 poly(lactic acid) Polymers 0.000 description 3
230000008488 polyadenylation Effects 0.000 description 3
239000004626 polylactic acid Substances 0.000 description 3
108091033319 polynucleotide Proteins 0.000 description 3
102000040430 polynucleotide Human genes 0.000 description 3
239000002157 polynucleotide Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000003753 real-time PCR Methods 0.000 description 3
230000001177 retroviral effect Effects 0.000 description 3
230000009870 specific binding Effects 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
238000012800 visualization Methods 0.000 description 3
108010047303 von Willebrand Factor Proteins 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 2
102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
238000012756 BrdU staining Methods 0.000 description 2
101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 2
235000014653 Carica parviflora Nutrition 0.000 description 2
ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
206010010356 Congenital anomaly Diseases 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000012545 EGF-like domains Human genes 0.000 description 2
108050002150 EGF-like domains Proteins 0.000 description 2
108091008794 FGF receptors Proteins 0.000 description 2
102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 2
101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 2
102100037362 Fibronectin Human genes 0.000 description 2
108010067306 Fibronectins Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
102100040615 Homeobox protein MSX-2 Human genes 0.000 description 2
101000967222 Homo sapiens Homeobox protein MSX-2 Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 2
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 2
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
206010022773 Intracranial pressure increased Diseases 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
102000007547 Laminin Human genes 0.000 description 2
108010085895 Laminin Proteins 0.000 description 2
241000714177 Murine leukemia virus Species 0.000 description 2
101100165560 Mus musculus Bmp7 gene Proteins 0.000 description 2
101100384865 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cot-1 gene Proteins 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
108010077077 Osteonectin Proteins 0.000 description 2
102000009890 Osteonectin Human genes 0.000 description 2
AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 description 2
108091093037 Peptide nucleic acid Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
241000276498 Pollachius virens Species 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
238000010240 RT-PCR analysis Methods 0.000 description 2
102000007591 Tartrate-Resistant Acid Phosphatase Human genes 0.000 description 2
108010032050 Tartrate-Resistant Acid Phosphatase Proteins 0.000 description 2
101150117115 V gene Proteins 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000005313 bioactive glass Substances 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000002981 blocking agent Substances 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
210000002449 bone cell Anatomy 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
210000002798 bone marrow cell Anatomy 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000022131 cell cycle Effects 0.000 description 2
230000003915 cell function Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000004568 cement Substances 0.000 description 2
XFIOKOXROGCUQX-UHFFFAOYSA-N chloroform;guanidine;phenol Chemical compound NC(N)=N.ClC(Cl)Cl.OC1=CC=CC=C1 XFIOKOXROGCUQX-UHFFFAOYSA-N 0.000 description 2
102000006533 chordin Human genes 0.000 description 2
108010008846 chordin Proteins 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
238000012875 competitive assay Methods 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
230000002950 deficient Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000011037 discontinuous sequential dilution Methods 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
210000002308 embryonic cell Anatomy 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
230000005284 excitation Effects 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
239000010931 gold Substances 0.000 description 2
230000012447 hatching Effects 0.000 description 2
230000035876 healing Effects 0.000 description 2
230000002440 hepatic effect Effects 0.000 description 2
238000013537 high throughput screening Methods 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
238000003384 imaging method Methods 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000003053 immunization Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
238000003119 immunoblot Methods 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
239000002502 liposome Substances 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000004020 luminiscence type Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
239000011707 mineral Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
238000011206 morphological examination Methods 0.000 description 2
238000010172 mouse model Methods 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
230000036963 noncompetitive effect Effects 0.000 description 2
230000009871 nonspecific binding Effects 0.000 description 2
239000002777 nucleoside Substances 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
238000000059 patterning Methods 0.000 description 2
238000002823 phage display Methods 0.000 description 2
238000002205 phenol-chloroform extraction Methods 0.000 description 2
230000035790 physiological processes and functions Effects 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000000644 propagated effect Effects 0.000 description 2
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
238000001742 protein purification Methods 0.000 description 2
239000012460 protein solution Substances 0.000 description 2
230000004850 protein–protein interaction Effects 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
230000008929 regeneration Effects 0.000 description 2
238000011069 regeneration method Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
238000000926 separation method Methods 0.000 description 2
230000011664 signaling Effects 0.000 description 2
239000002904 solvent Substances 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
238000003860 storage Methods 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000008685 targeting Effects 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
210000002303 tibia Anatomy 0.000 description 2
238000003325 tomography Methods 0.000 description 2
238000011200 topical administration Methods 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
229910052720 vanadium Inorganic materials 0.000 description 2
210000005167 vascular cell Anatomy 0.000 description 2
102100036537 von Willebrand factor Human genes 0.000 description 2
CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 1
239000013607 AAV vector Substances 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
208000010370 Adenoviridae Infections Diseases 0.000 description 1
206010060931 Adenovirus infection Diseases 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102100036601 Aggrecan core protein Human genes 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
241000242757 Anthozoa Species 0.000 description 1
244000105975 Antidesma platyphyllum Species 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
101150061927 BMP2 gene Proteins 0.000 description 1
239000004342 Benzoyl peroxide Substances 0.000 description 1
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 1
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
206010070918 Bone deformity Diseases 0.000 description 1
208000020084 Bone disease Diseases 0.000 description 1
102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 1
108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 1
102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
244000056139 Brassica cretica Species 0.000 description 1
235000003351 Brassica cretica Nutrition 0.000 description 1
235000003343 Brassica rupestris Nutrition 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
229940123150 Chelating agent Drugs 0.000 description 1
241000243321 Cnidaria Species 0.000 description 1
108010048623 Collagen Receptors Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
108010066259 Collagraft Proteins 0.000 description 1
206010062344 Congenital musculoskeletal anomaly Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
206010070666 Cortical dysplasia Diseases 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
208000009833 Craniotelencephalic dysplasia Diseases 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
101100447432 Danio rerio gapdh-2 gene Proteins 0.000 description 1
102000004237 Decorin Human genes 0.000 description 1
108090000738 Decorin Proteins 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
208000005335 Dentin Dysplasia Diseases 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
208000012239 Developmental disease Diseases 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
206010058314 Dysplasia Diseases 0.000 description 1
238000008157 ELISA kit Methods 0.000 description 1
238000004435 EPR spectroscopy Methods 0.000 description 1
206010014561 Emphysema Diseases 0.000 description 1
101710121417 Envelope glycoprotein Proteins 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
102100035290 Fibroblast growth factor 13 Human genes 0.000 description 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 1
102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
108091092584 GDNA Proteins 0.000 description 1
101150112014 Gapdh gene Proteins 0.000 description 1
208000032612 Glial tumor Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
108060003393 Granulin Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
108010034791 Heterochromatin Proteins 0.000 description 1
108700005087 Homeobox Genes Proteins 0.000 description 1
101000999998 Homo sapiens Aggrecan core protein Proteins 0.000 description 1
101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 1
101900065606 Human cytomegalovirus Immediate early protein IE1 Proteins 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
102000000507 Integrin alpha2 Human genes 0.000 description 1
108010028750 Integrin-Binding Sialoprotein Proteins 0.000 description 1
102000016921 Integrin-Binding Sialoprotein Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
208000032984 Intraoperative Complications Diseases 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
208000000676 Malformations of Cortical Development Diseases 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000029725 Metabolic bone disease Diseases 0.000 description 1
102000005741 Metalloproteases Human genes 0.000 description 1
108010006035 Metalloproteases Proteins 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
241000283283 Orcinus orca Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
206010049088 Osteopenia Diseases 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
108010043958 Peptoids Proteins 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
108010066717 Q beta Replicase Proteins 0.000 description 1
208000004756 Respiratory Insufficiency Diseases 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
208000034189 Sclerosis Diseases 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
102000007000 Tenascin Human genes 0.000 description 1
108010008125 Tenascin Proteins 0.000 description 1
206010043276 Teratoma Diseases 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
208000002495 Uterine Neoplasms Diseases 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
108010031318 Vitronectin Proteins 0.000 description 1
102100035140 Vitronectin Human genes 0.000 description 1
241000269370 Xenopus <genus> Species 0.000 description 1
239000005083 Zinc sulfide Substances 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
238000010306 acid treatment Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000012190 activator Substances 0.000 description 1
208000011589 adenoviridae infectious disease Diseases 0.000 description 1
230000000274 adsorptive effect Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000003314 affinity selection Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000000556 agonist Substances 0.000 description 1
PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical group OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000008365 aqueous carrier Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000012098 association analyses Methods 0.000 description 1
229910001566 austenite Inorganic materials 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
235000019400 benzoyl peroxide Nutrition 0.000 description 1
239000003462 bioceramic Substances 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
239000003139 biocide Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
238000005415 bioluminescence Methods 0.000 description 1
230000029918 bioluminescence Effects 0.000 description 1
QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
230000037176 bone building Effects 0.000 description 1
239000002639 bone cement Substances 0.000 description 1
229940112869 bone morphogenetic protein Drugs 0.000 description 1
239000000316 bone substitute Substances 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
229910001634 calcium fluoride Inorganic materials 0.000 description 1
239000000920 calcium hydroxide Substances 0.000 description 1
229910001861 calcium hydroxide Inorganic materials 0.000 description 1
101150039352 can gene Proteins 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
210000003710 cerebral cortex Anatomy 0.000 description 1
208000023397 cerebral cortical dysplasia Diseases 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
239000013626 chemical specie Substances 0.000 description 1
239000005081 chemiluminescent agent Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
210000003109 clavicle Anatomy 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000012761 co-transfection Methods 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000000805 composite resin Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
208000018631 connective tissue disease Diseases 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
229910052878 cordierite Inorganic materials 0.000 description 1
239000011258 core-shell material Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
239000013078 crystal Substances 0.000 description 1
239000002178 crystalline material Substances 0.000 description 1
DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
238000012258 culturing Methods 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000006735 deficit Effects 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000010586 diagram Methods 0.000 description 1
108010032337 diaminobenzidine peroxidase Proteins 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 description 1
239000000539 dimer Substances 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
239000012636 effector Substances 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000007071 enzymatic hydrolysis Effects 0.000 description 1
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
230000001973 epigenetic effect Effects 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
229940011871 estrogen Drugs 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
102000015694 estrogen receptors Human genes 0.000 description 1
108010038795 estrogen receptors Proteins 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000009647 facial growth Effects 0.000 description 1
239000010433 feldspar Substances 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
108060002894 fibrillar collagen Proteins 0.000 description 1
102000013373 fibrillar collagen Human genes 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 1
229910052587 fluorapatite Inorganic materials 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
210000002454 frontal bone Anatomy 0.000 description 1
239000005350 fused silica glass Substances 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
230000007045 gastrulation Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
239000006112 glass ceramic composition Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
208000035474 group of disease Diseases 0.000 description 1
229960004198 guanidine Drugs 0.000 description 1
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
235000009424 haa Nutrition 0.000 description 1
230000035931 haemagglutination Effects 0.000 description 1
208000024963 hair loss Diseases 0.000 description 1
230000003676 hair loss Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
210000004458 heterochromatin Anatomy 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
229920000140 heteropolymer Polymers 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000010562 histological examination Methods 0.000 description 1
210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 1
WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
229940091173 hydantoin Drugs 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
229940127121 immunoconjugate Drugs 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
238000000760 immunoelectrophoresis Methods 0.000 description 1
238000010185 immunofluorescence analysis Methods 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000012296 in situ hybridization assay Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
238000007917 intracranial administration Methods 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
230000001678 irradiating effect Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
210000000867 larynx Anatomy 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
210000004373 mandible Anatomy 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000011572 manganese Substances 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000009245 menopause Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
239000010445 mica Substances 0.000 description 1
229910052618 mica group Inorganic materials 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000002557 mineral fiber Substances 0.000 description 1
239000003607 modifier Substances 0.000 description 1
238000000329 molecular dynamics simulation Methods 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
230000003990 molecular pathway Effects 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
235000010460 mustard Nutrition 0.000 description 1
239000002159 nanocrystal Substances 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
230000024121 nodulation Effects 0.000 description 1
238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
238000003499 nucleic acid array Methods 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
238000002966 oligonucleotide array Methods 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000000849 parathyroid Effects 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000001936 parietal effect Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000008196 pharmacological composition Substances 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000010399 physical interaction Effects 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
230000007505 plaque formation Effects 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
229950008885 polyglycolic acid Drugs 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
238000011176 pooling Methods 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
229940076376 protein agonist Drugs 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000004853 protein function Effects 0.000 description 1
150000003235 pyrrolidines Chemical class 0.000 description 1
239000002096 quantum dot Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000000611 regression analysis Methods 0.000 description 1
201000004193 respiratory failure Diseases 0.000 description 1
230000004044 response Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
150000003290 ribose derivatives Chemical group 0.000 description 1
125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
238000011808 rodent model Methods 0.000 description 1
YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
229960001860 salicylate Drugs 0.000 description 1
210000003786 sclera Anatomy 0.000 description 1
230000002784 sclerotic effect Effects 0.000 description 1
206010039722 scoliosis Diseases 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000012679 serum free medium Substances 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
231100001055 skeletal defect Toxicity 0.000 description 1
230000009645 skeletal growth Effects 0.000 description 1
230000012488 skeletal system development Effects 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000001540 sodium lactate Substances 0.000 description 1
229940005581 sodium lactate Drugs 0.000 description 1
235000011088 sodium lactate Nutrition 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
208000029277 split foot Diseases 0.000 description 1
238000007447 staining method Methods 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
230000009772 tissue formation Effects 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000012301 transgenic model Methods 0.000 description 1
229910052723 transition metal Inorganic materials 0.000 description 1
150000003624 transition metals Chemical class 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
235000019731 tricalcium phosphate Nutrition 0.000 description 1
229940078499 tricalcium phosphate Drugs 0.000 description 1
239000013638 trimer Substances 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
206010046766 uterine cancer Diseases 0.000 description 1
GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
210000005166 vasculature Anatomy 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
102000009310 vitamin D receptors Human genes 0.000 description 1
108050000156 vitamin D receptors Proteins 0.000 description 1
229960001134 von willebrand factor Drugs 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000010456 wollastonite Substances 0.000 description 1
229910052882 wollastonite Inorganic materials 0.000 description 1
229910052984 zinc sulfide Inorganic materials 0.000 description 1
DRDVZXDWVBGGMH-UHFFFAOYSA-N zinc;sulfide Chemical compound [S-2].[Zn+2] DRDVZXDWVBGGMH-UHFFFAOYSA-N 0.000 description 1